 | • レポートコード：STR-DC014 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：製薬 |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、コロイド（血漿）の世界市場について調査・分析し、調査手法、市場概要、種類別（天然型コロイド、合成型コロイド）分析、用途別（広範囲型火傷、大量血液または血漿損失）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・コロイド（血漿）の世界市場：種類別（天然型コロイド、合成型コロイド） ・コロイド（血漿）の世界市場：用途別（広範囲型火傷、大量血液または血漿損失） ・コロイド（血漿）の世界市場：地域別 ・企業概要 |
Colloids (blood plasma) can be defined as the liquid component of whole blood, comprising up to 60% of total blood volume, which contains proteins such as serum fibrinogen, albumins, and globulins. Other factors present in blood plasma include clotting factors, glucose, hormones, mineral ions, and carbon dioxide, which enable the use of blood plasma in the treatment of excessive bleeding and other blood related diseases such as gastrointestinal bleeding and hepatitis B virus infection.
Increasing prevalence of chronic and severe diseases around the globe is expected to drive the market in the next few years. According to the Centers for Disease Control & Prevention (CDC), 6 in every 10 adults in America are suffering through chronic diseases and 4 in every 10 adults have 2 or more chronic diseases. Further stated, heart diseases, cancers, chronic lung diseases, and chronic kidney diseases, are some of the chronic diseases which are the leading causes of death in North America. Moreover, rising number of severe diseases in low to middle income countries across the globe is expected to support the market growth.
Increasing prevalence of chronic gastrointestinal bleeding disorders, rising incidences of liver diseases and disorders, and growing number of accidents across the globe resulting in extensive blood loss are some of the factors notably increasing the demand for colloids (blood plasma). According to the National Institute of Diabetes & Digestive and Kidney Diseases, more than 100,000 people suffer from gastrointestinal tract bleeding disorders in the U.S. Colloids (blood plasma) treatment recovers blood and blood plasma volume in the body after heavy blood loss, and thus, the demand for natural and synthetic blood plasma has been increasing. China imported more than 60% of its total blood plasma consumption from the U.S. in 2016 and the demand has been increasing by 15% annually since then. High prevalence of hepatitis B virus in Asian countries is expected to upsurge the demand for blood plasma for effective treatments.
Segmental Insights
Global colloids (blood plasma) market is segmented into type, application, and region.
Based on type, the market is segmented into natural type colloids and synthetic type colloids. Natural type colloids consist of water and proteins such as fibrinogen, globulins, and serum albumins. Natural plasma is preferred for the treatment of people suffering from shock, burns, trauma, liver diseases, and hepatitis B virus infection. Rising awareness regarding the benefits of blood donation in increasing production of colloids (blood plasma) and increasing prevalence of hepatitis B virus infection in developing regions including Asia Pacific and Africa, are some of the key factors driving the growth of the natural type colloid segment. Synthetic type colloids are derived from fluorine and carbon containing chemicals that are chemically inert in nature and highly effective in dissolving, absorbing, and transporting oxygen in lungs and throughout the body. The robust nature of synthetic blood plasma and its quality of surviving harsh environments such as no-refrigeration and pre-hospital are expected to drive the growth of the synthetic type colloids segment.
Regional Insights
Based on region, the market is segmented into North America, Europe, Asia Pacific (APAC), and South America and the Middle East & Africa.
North America dominates the global colloids (blood plasma) market. Increasing incidences of people suffering from burns, especially over the past few years, have been contributing to the growth of the colloids market in North America. According to the National Burn Repository (NBR) of the American Burn Association (ABA), in 2016, more than 486,000 burn injuries were recorded in the U.S., which received medical treatment for severe burns. High effectiveness of blood plasma treatment in severe burn injuries and growing awareness regarding the treatment are projected to bolster market growth in the future. The prevalence of liver disorders among Chinese patients is providing impetus to the import of human serum albumin from the U.S., with a consumption of 300 tons of human serum albumin in 2016. In 2016, 60% of the total consumed human serum albumin in China was imported from the U.S., which has positively influenced the North America colloids market.
Europe accounts for optimum share of the global market. The steady rise in the number of injuries resulting in blood loss is driving the Europe colloids (blood plasma) market. According to the Annual Accident Report of the European Road Safety Observatory, the number of injuries due to accidents resulting in heavy blood loss increased in Europe from around 1.39 million in 2013 to 1.48 million in 2016. Rapid recovery of blood plasma volume due to colloid treatment and increasing number of colloid manufacturers in the region are further aiding market growth.
Key Players
Some of the major players of the global colloids (blood plasma) market are, CSL Behring, Baxter, Grifols, S.A., Octapharma, Shanghai RAAS Blood Products Co., Ltd., Shandong Taibang Biological Products Co. Ltd (China Biologic Products, Inc.), Hualan Biological Engineering Inc., Chengdu Rongsheng Pharmaceuticals Co., Ltd. (China National Pharmaceutical Group Corporation), and Adma Biologics Inc.
TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Colloids (Blood Plasma) Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.6 Global Colloids (Blood Plasma) Revenue and Market Share by Manufacturer (2018)
3.7 Market Competition Trend
4 By Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Natural Type Colloids
4.2.1 Market Size & Forecast (Value)
4.3 Synthetic Type Colloids
4.3.1 Market Size & Forecast (Value)
5 By Application Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Extensive Burns
5.2.1 Market Size & Forecast (Value)
5.3 Massive Blood or Plasma Loss
5.3.1 Market Size & Forecast (Value)
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 America
6.2.1 North America
6.2.1.1 U.S.
6.2.1.1.1 By Type
6.2.1.1.2 By Application
6.2.1.2 Canada
6.2.1.2.1 By Type
6.2.1.2.2 By Application
6.2.1.3 Mexico
6.2.1.3.1 By Type
6.2.1.3.2 By Application
6.2.2 Latin America
6.2.4.1 By Type
6.2.4.2 By Application
6.3 Europe
6.3.1 Market Size & Forecast (Value)
6.3.2 Germany
6.3.2.1 By Type
6.3.2.2 By Application
6.3.3 France
6.3.3.1 By Type
6.3.3.2 By Application
6.3. 4 U.K
6.3.4.1 By Type
6.3.4.2 By Application
6.3.5 Italy
6.3.5.1 By Type
6.3.5.2 By Application
6.3.6 Spain
6.3.6.1 By Type
6.3.6.2 By Application
6.3.7 Rest of Europe
6.3.7.1 By Type
6.3.7.2 By Application
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
6.4.2 Japan
6.4.2.1 By Type
6.4.2.2 By Application
6.4.3 China
6.4.3.1 By Type
6.4.3.2 By Application
6.4.4 Australia
6.4.4.1 By Type
6.4.4.2 By Application
6.4.5 India
6.4.5.1 By Type
6.4.5.2 By Application
6.4.6 South Korea
6.4.6.1 By Type
6.4.6.2 By Application
6.4.7 Rest of Asia-Pacific
6.4.7.1 By Type
6.4.7.2 By Application
6.5 Middle East & Africa
6.5.1 Market Size & Forecast (Value)
6.5.2 Saudi Arabia
6.5.2.1 By Type
6.5.2.2 By Application
6.5.3 South Africa
6.5.3.1 By Type
6.5.3.2 By Application
6.5.4 Kuwait
6.5.4.1 By Type
6.5.4.2 By Application
6.5.5 Rest of Middle East & Africa
6.5.5.1 By Type
6.5.5.2 By Application
7 Company Profile
7.1 CSL Behring
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 Baxter
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 Grifols, S.A.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 Octapharma
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Shanghai RAAS Blood Products Co., Ltd.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 Shandong Taibang Biological Products Co. Ltd (China Biologic Products, Inc.)
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Hualan Biological Engineering Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 Chengdu Rongsheng Pharmaceuticals Co., Ltd. (China National Pharmaceutical Group Corporation)
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
7.9 Adma Biologics Inc.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
LIST OF TABLES
TABLE 1 Global Colloids (Blood Plasma) Market Share, By Type, 2016–2026 ($Million)
TABLE 2 Natural Type Colloids Colloids (Blood Plasma) Market Share, By Region, 2016–2026 ($ Million)
TABLE 3 Synthetic Type Colloids Colloids (Blood Plasma) Market Share, By Region, 2016–2026, ($ Million)
TABLE 4 Global Colloids (Blood Plasma) Market Share, By Application, 2016–2026 ($Million)
TABLE 5 Global Colloids (Blood Plasma) Market through Extensive Burns, By Region, 2016–2026 ($ Million)
TABLE 6 Global Colloids (Blood Plasma) Market Share Value, 2016–2026 ($Million)
TABLE 7 America Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 8 America Colloids (Blood Plasma) Market Share value, By Type, 2016–2026 ($Million)
TABLE 9 America Colloids (Blood Plasma) Market Share value, By Application, 2016–2026 ($Million)
TABLE 10 U.S. Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 11 U.S. Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 12 Canada Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 13 Canada Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 14 Mexico Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 15 Mexico Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 16 Latin America Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 17 Latin America Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 18 Europe Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 19 Europe Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 20 Europe Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 21 Germany Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 22 Germany Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 23 France Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 24 France Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 25 UK Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 26 UK Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 27 Italy Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 28 Italy Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 29 Spain Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 30 Spain Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 31 Rest of Europe Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 32 Rest of Europe Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 33 Asia-Pacific Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 34 Asia-Pacific Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 35 Asia-Pacific Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 36 Japan Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 37 Japan Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 38 China Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 39 China Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 40 Australia Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 41 Australia Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 42 India Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 43 India Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 44 South Korea Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 45 South Korea Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 46 Rest of Asia-pacific Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 47 Rest of Asia-pacific Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 48 LAMEA Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 49 LAMEA Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 50 LAMEA Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 51 Saudi Arabia Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 52 Saudi Arabia Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 53 South Africa Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 54 South Africa Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 55 South Africa Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 56 Brazil Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 57 Brazil Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 58 Rest of LAMEA Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 59 Rest of LAMEA Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
List of Figures
FIGURE 1 Global Colloids (Blood Plasma) Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Colloids (Blood Plasma) Market, Market Share Analysis, 2018
FIGURE 9 Global Colloids (Blood Plasma) Market, 2016–2026
FIGURE 10 U.S. Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 11 Canada Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 12 Mexico Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 13 Germany Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 14 France Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 15 UK Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 16 Italy Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 17 Spain Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 18 REST OF EUROPE Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 19 Japan Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 20 China Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 21 Australia Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 22 India Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 23 South Korea Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 24 Rest of Asia-pacific Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 25 Saudi Arabia Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 26 South Africa Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 27 Brazil Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 28 Rest of LAMEA Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 29 CSL Behring: Revenue Analysis, ($million)
FIGURE 30 CSL Behring: Segment Revenue 2018 (%)
LIST OF TABLES
TABLE 1 Global Colloids (Blood Plasma) Market Share, By Type, 2016–2026 ($Million)
TABLE 2 Natural Type Colloids Colloids (Blood Plasma) Market Share, By Region, 2016–2026 ($ Million)
TABLE 3 Synthetic Type Colloids Colloids (Blood Plasma) Market Share, By Region, 2016–2026, ($ Million)
TABLE 4 Global Colloids (Blood Plasma) Market Share, By Application, 2016–2026 ($Million)
TABLE 5 Global Colloids (Blood Plasma) Market through Extensive Burns, By Region, 2016–2026 ($ Million)
TABLE 6 Global Colloids (Blood Plasma) Market Share Value, 2016–2026 ($Million)
TABLE 7 America Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 8 America Colloids (Blood Plasma) Market Share value, By Type, 2016–2026 ($Million)
TABLE 9 America Colloids (Blood Plasma) Market Share value, By Application, 2016–2026 ($Million)
TABLE 10 U.S. Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 11 U.S. Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 12 Canada Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 13 Canada Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 14 Mexico Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 15 Mexico Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 16 Latin America Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 17 Latin America Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 18 Europe Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 19 Europe Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 20 Europe Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 21 Germany Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 22 Germany Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 23 France Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 24 France Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 25 UK Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 26 UK Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 27 Italy Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 28 Italy Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 29 Spain Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 30 Spain Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 31 Rest of Europe Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 32 Rest of Europe Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 33 Asia-Pacific Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 34 Asia-Pacific Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 35 Asia-Pacific Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 36 Japan Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 37 Japan Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 38 China Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 39 China Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 40 Australia Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 41 Australia Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 42 India Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 43 India Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 44 South Korea Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 45 South Korea Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 46 Rest of Asia-pacific Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 47 Rest of Asia-pacific Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 48 LAMEA Colloids (Blood Plasma) Market Share Value, By Country, 2016–2026 ($Million)
TABLE 49 LAMEA Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 50 LAMEA Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 51 Saudi Arabia Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 52 Saudi Arabia Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 53 South Africa Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 54 South Africa Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 55 South Africa Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 56 Brazil Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 57 Brazil Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
TABLE 58 Rest of LAMEA Colloids (Blood Plasma) Market share, By Type, 2016–2026 ($Million)
TABLE 59 Rest of LAMEA Colloids (Blood Plasma) Market share, By Application, 2016–2026 ($Million)
List of Figures
FIGURE 1 Global Colloids (Blood Plasma) Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Colloids (Blood Plasma) Market, Market Share Analysis, 2018
FIGURE 9 Global Colloids (Blood Plasma) Market, 2016–2026
FIGURE 10 U.S. Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 11 Canada Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 12 Mexico Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 13 Germany Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 14 France Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 15 UK Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 16 Italy Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 17 Spain Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 18 REST OF EUROPE Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 19 Japan Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 20 China Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 21 Australia Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 22 India Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 23 South Korea Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 24 Rest of Asia-pacific Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 25 Saudi Arabia Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 26 South Africa Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 27 Brazil Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 28 Rest of LAMEA Colloids (Blood Plasma) Market Share, 2016–2026 ($Million)
FIGURE 29 CSL Behring: Revenue Analysis, ($million)
FIGURE 30 CSL Behring: Segment Revenue 2018 (%)